News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,027 Results
Type
Article (14125)
Company Profile (282)
Press Release (250620)
Section
Business (79466)
Career Advice (152)
Deals (13221)
Drug Delivery (35)
Drug Development (50412)
Employer Resources (31)
FDA (5706)
Job Trends (5125)
News (144314)
Policy (10025)
Tag
Academia (906)
Alliances (21615)
Alzheimer's disease (801)
Antibody-drug conjugate (ADC) (78)
Approvals (5711)
Artificial intelligence (99)
Bankruptcy (102)
Best Places to Work (4560)
Biotechnology (232)
Breast cancer (132)
Cancer (1157)
Cardiovascular disease (92)
Career advice (132)
CAR-T (99)
Cell therapy (288)
Clinical research (40628)
Collaboration (454)
Compensation (187)
COVID-19 (1028)
C-suite (124)
Cystic fibrosis (75)
Data (1190)
Diabetes (109)
Diagnostics (1282)
Earnings (29327)
Events (47814)
Executive appointments (369)
FDA (6237)
Funding (425)
Gene editing (79)
Gene therapy (210)
GLP-1 (341)
Government (1072)
Healthcare (6580)
Infectious disease (1082)
Inflammatory bowel disease (106)
IPO (7250)
Job creations (859)
Job search strategy (127)
Layoffs (197)
Legal (1384)
Lung cancer (165)
Manufacturing (105)
Medical device (2581)
Medtech (2582)
Mergers & acquisitions (6212)
Metabolic disorders (328)
Neuroscience (1127)
NextGen: Class of 2025 (2013)
Non-profit (852)
Northern California (1394)
Obesity (170)
Opinion (98)
Parkinson's disease (90)
Patents (93)
People (25394)
Phase I (14341)
Phase II (18904)
Phase III (11944)
Pipeline (557)
Postmarket research (852)
Preclinical (6008)
Radiopharmaceuticals (210)
Rare diseases (255)
Real estate (1414)
Regulatory (8474)
Research institute (935)
Series A (83)
Southern California (1238)
Startups (1969)
United States (10967)
Vaccines (193)
Weight loss (97)
Date
Today (78)
Last 7 days (456)
Last 30 days (1597)
Last 365 days (20404)
2025 (3204)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11739)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Asia (17128)
Australia (2898)
California (3178)
Canada (983)
China (283)
Colorado (121)
Connecticut (132)
Delaware (76)
Europe (36828)
Florida (368)
Georgia (93)
Illinois (196)
Indiana (78)
Maryland (409)
Massachusetts (2511)
Minnesota (124)
New Jersey (792)
New York (874)
North Carolina (487)
Northern California (1394)
Ohio (99)
Pennsylvania (594)
South America (207)
Southern California (1238)
Texas (351)
Washington State (297)
265,027 Results for "corvidia therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Deals
Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk
June 11, 2020 13:20 UTC Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash Sofinnova Partners co-founded Corvidia as its sole seed financial investor in 2015 with serial entrepreneur Michael Davidson PARIS--( BUSINESS WIRE )-- Sofinnova Partners , a leading European life sciences venture capital firm based in Paris, London and Milan, announced today the sale of its portfolio company Corvidia Therapeutics to Novo Nordisk, for $2.1 bi
June 11, 2020
·
3 min read
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
Deals
Novo Nordisk Snaps Up Corvidia Therapeutics in Deal Worth Up to $2.1 Billion
Under terms of the deal, Novo Nordisk paid $725 million upfront to Sofinnova for the Waltham, Mass.-based Corvidia, a company focused on the development of transformational therapies for cardio-renal diseases.
June 11, 2020
·
2 min read
·
Alex Keown
Press Releases
Allogene Therapeutics Announces Participation in March Investor Conference
February 26, 2025
·
2 min read
Press Releases
C4 Therapeutics to Participate in Upcoming March Investor Conferences
February 24, 2025
·
1 min read
Press Releases
AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference
March 3, 2025
·
1 min read
Drug Development
Corvidia Therapeutics Initiates Phase 2b Dose-Finding Study for Ziltivekimab
Corvidia Therapeutics Inc., a clinical stage biotechnology company, announced today the initiation of patient screening for a Phase 2b dose-finding study of ziltivekimab
June 13, 2019
·
4 min read
Business
Ablexis Announces Licensing Agreement with Corvidia Therapeutics
Ablexis grants rights to Corvidia to use the AlivaMab Mouse™ platform for research, development and potential commercialization of antibodies
January 3, 2019
·
1 min read
Press Releases
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
February 20, 2025
·
1 min read
1 of 26,503
Next
